LIZABETH SHEETS: Open Payments
NPI 1144900861 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 56 payments from 18 companies in 2025. Trend: 2023 $352 · 2024 $1,883 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $102 |
| Lundbeck LLC | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Almatica Pharma LLC | 3 | $65 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $40 |
Products named: VRAYLAR, REXULTI, CAPLYTA, LOREEV XR, INGREZZA, SPRAVATO, ABILIFY MAINTENA, Auvelity.
Industry payments across IA — which companies pay providers there.
